vs
Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and ROGERS CORP (ROG). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $200.5M, roughly 1.9× ROGERS CORP). ROGERS CORP runs the higher net margin — 2.2% vs -19.6%, a 21.9% gap on every dollar of revenue. On growth, ROGERS CORP posted the faster year-over-year revenue change (5.2% vs 3.8%). Over the past eight quarters, P3 Health Partners Inc.'s revenue compounded faster (-0.5% CAGR vs -3.3%).
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
Rogers Corporation is a specialty engineered materials company headquartered in Chandler, Arizona.
PIII vs ROG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $384.8M | $200.5M |
| Net Profit | $-75.5M | $4.5M |
| Gross Margin | — | 32.2% |
| Operating Margin | -40.0% | — |
| Net Margin | -19.6% | 2.2% |
| Revenue YoY | 3.8% | 5.2% |
| Net Profit YoY | -28.8% | 421.4% |
| EPS (diluted) | $-23.08 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $200.5M | ||
| Q4 25 | $384.8M | $201.5M | ||
| Q3 25 | $345.3M | $216.0M | ||
| Q2 25 | $355.8M | $202.8M | ||
| Q1 25 | $373.2M | $190.5M | ||
| Q4 24 | $370.7M | $192.2M | ||
| Q3 24 | $362.1M | $210.3M | ||
| Q2 24 | $379.2M | $214.2M |
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-75.5M | $4.6M | ||
| Q3 25 | $-31.6M | $8.6M | ||
| Q2 25 | $-20.4M | $-73.6M | ||
| Q1 25 | $-20.5M | $-1.4M | ||
| Q4 24 | $-58.6M | $-500.0K | ||
| Q3 24 | $-46.5M | $10.7M | ||
| Q2 24 | $-12.0M | $8.1M |
| Q1 26 | — | 32.2% | ||
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 31.6% | ||
| Q1 25 | — | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 34.1% |
| Q1 26 | — | — | ||
| Q4 25 | -40.0% | 3.5% | ||
| Q3 25 | -12.8% | 7.3% | ||
| Q2 25 | -9.6% | -33.3% | ||
| Q1 25 | -10.2% | -0.2% | ||
| Q4 24 | -37.4% | -6.6% | ||
| Q3 24 | -29.5% | 6.9% | ||
| Q2 24 | -8.3% | 5.3% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | -19.6% | 2.3% | ||
| Q3 25 | -9.1% | 4.0% | ||
| Q2 25 | -5.7% | -36.3% | ||
| Q1 25 | -5.5% | -0.7% | ||
| Q4 24 | -15.8% | -0.3% | ||
| Q3 24 | -12.8% | 5.1% | ||
| Q2 24 | -3.2% | 3.8% |
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-23.08 | $0.20 | ||
| Q3 25 | $-9.67 | $0.48 | ||
| Q2 25 | $-6.23 | $-4.00 | ||
| Q1 25 | $-6.28 | $-0.08 | ||
| Q4 24 | $-23.13 | $-0.04 | ||
| Q3 24 | $-15.70 | $0.58 | ||
| Q2 24 | $-7.37 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.0M | $195.8M |
| Total DebtLower is stronger | $228.4M | — |
| Stockholders' EquityBook value | $-155.2M | $1.2B |
| Total Assets | $656.6M | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $195.8M | ||
| Q4 25 | $25.0M | $197.0M | ||
| Q3 25 | $37.7M | $167.8M | ||
| Q2 25 | $38.6M | $157.2M | ||
| Q1 25 | $40.1M | $175.6M | ||
| Q4 24 | $38.8M | $159.8M | ||
| Q3 24 | $63.0M | $146.4M | ||
| Q2 24 | $73.1M | $119.9M |
| Q1 26 | — | — | ||
| Q4 25 | $228.4M | — | ||
| Q3 25 | $252.8M | — | ||
| Q2 25 | $182.0M | — | ||
| Q1 25 | $171.1M | — | ||
| Q4 24 | $108.9M | — | ||
| Q3 24 | $133.2M | — | ||
| Q2 24 | $133.1M | — |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $-155.2M | $1.2B | ||
| Q3 25 | $-18.7M | $1.2B | ||
| Q2 25 | $44.5M | $1.2B | ||
| Q1 25 | $63.3M | $1.3B | ||
| Q4 24 | $75.9M | $1.3B | ||
| Q3 24 | $120.5M | $1.3B | ||
| Q2 24 | $166.8M | $1.3B |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $656.6M | $1.4B | ||
| Q3 25 | $683.6M | $1.4B | ||
| Q2 25 | $731.6M | $1.5B | ||
| Q1 25 | $783.9M | $1.5B | ||
| Q4 24 | $783.4M | $1.5B | ||
| Q3 24 | $833.3M | $1.5B | ||
| Q2 24 | $892.8M | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.09× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.80× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.7M | $5.8M |
| Free Cash FlowOCF − Capex | — | $1.1M |
| FCF MarginFCF / Revenue | — | 0.5% |
| Capex IntensityCapex / Revenue | — | 2.3% |
| Cash ConversionOCF / Net Profit | — | 1.29× |
| TTM Free Cash FlowTrailing 4 quarters | — | $70.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $5.8M | ||
| Q4 25 | $-25.7M | $46.9M | ||
| Q3 25 | $-15.4M | $28.9M | ||
| Q2 25 | $-16.6M | $13.7M | ||
| Q1 25 | $-33.5M | $11.7M | ||
| Q4 24 | $-57.2M | $33.7M | ||
| Q3 24 | $-22.6M | $42.4M | ||
| Q2 24 | $-10.2M | $22.9M |
| Q1 26 | — | $1.1M | ||
| Q4 25 | — | $42.2M | ||
| Q3 25 | — | $21.2M | ||
| Q2 25 | — | $5.6M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $18.3M | ||
| Q3 24 | — | $25.2M | ||
| Q2 24 | — | $8.8M |
| Q1 26 | — | 0.5% | ||
| Q4 25 | — | 20.9% | ||
| Q3 25 | — | 9.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 9.5% | ||
| Q3 24 | — | 12.0% | ||
| Q2 24 | — | 4.1% |
| Q1 26 | — | 2.3% | ||
| Q4 25 | — | 2.3% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | 0.0% | 8.0% | ||
| Q3 24 | 0.0% | 8.2% | ||
| Q2 24 | 0.0% | 6.6% |
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
ROG
Segment breakdown not available.
